Trials / Completed
CompletedNCT01769560
MeFirst: A Tailored Intervention to HPV Vaccine Decision Making
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 661 (actual)
- Sponsor
- University of Michigan · Academic / Other
- Sex
- Female
- Age
- 18 Years – 26 Years
- Healthy volunteers
- Accepted
Summary
This study will test whether a tailored, online educational intervention increases HPV vaccine uptake and intent among female college students.
Detailed description
MeFirst is the first web-based, online, educational tool designed to promote Human Papillomavirus (HPV) vaccine awareness and understanding in an effort to improve HPV vaccine intent and uptake among female university students. HPV is the most common sexually transmitted infection and causes genital warts and cancer. The HPV vaccine has been recommended for girls ages 11-26 since 2006, yet vaccination rates remain low. Tailored online interventions may be more effective tools to promote behavior change among college students than traditional static interventions. The proposed study is a randomized controlled trial testing the efficacy of the MeFirst tool vs. standard static educational material on increasing HPV vaccination intent and uptake among female university students aged 18-26.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | MeFirst Tailored Intervention | Participants will be lead through MeFirst, an interactive web-based tool that is tailored to their responses during the survey. This tool provides information regarding HPV Vaccination. |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2014-04-01
- Completion
- 2014-04-01
- First posted
- 2013-01-16
- Last updated
- 2015-07-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01769560. Inclusion in this directory is not an endorsement.